In the USA, mortality among patients with chronic kidney disease (CKD) and end-stage renal disease has declined over the past two decades. By contrast, new data indicate that the rate of CKD-associated deaths is increasing worldwide. This important finding highlights CKD as a major contributor to global morbidity and mortality.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Association of renal resistive indices with kidney disease progression and mortality
BMC Nephrology Open Access 28 November 2023
-
Value of radiomics-based two-dimensional ultrasound for diagnosing early diabetic nephropathy
Scientific Reports Open Access 22 November 2023
-
Cultural adaptation and validation of the Malay Chronic Kidney Disease Self-management instrument (MCKD-SM)
BMC Nephrology Open Access 01 December 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–2047 (2007).
US Renal Data System. USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease in the United States. usrds.org [online], (2014).
Roderick, P. et al. Simulation model of renal replacement therapy: predicting future demand in England. Nephrol. Dial. Transplant. 19, 692–701 (2004).
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171 (2015).
Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012).
Murray, C. J. et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 380, 2055–2058 (2012).
Matsushita, K. et al. Cohort profile: the chronic kidney disease prognosis consortium. Int. J. Epidemiol. 42, 1660–1668 (2013).
Kovesdy, C. P. & Kalantar-Zadeh, K. Enter the dragon: a Chinese epidemic of chronic kidney disease? Lancet 379, 783–785 (2012).
Zhang, L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379, 815–822 (2012).
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V. & Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365–3370 (2005).
Acknowledgements
The authors' work is supported by the NIH/NIDDK grants R01-DK096920 (C.P.K), U01-DK102163 (C.P.K), and K23-DK102903 (C.M.R). C.P.K. is an employee of the US Department of Veterans Affairs. The views expressed in this work are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Rhee, C., Kovesdy, C. Spotlight on CKD deaths—increasing mortality worldwide. Nat Rev Nephrol 11, 199–200 (2015). https://doi.org/10.1038/nrneph.2015.25
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2015.25
This article is cited by
-
Association of renal resistive indices with kidney disease progression and mortality
BMC Nephrology (2023)
-
Value of radiomics-based two-dimensional ultrasound for diagnosing early diabetic nephropathy
Scientific Reports (2023)
-
Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study
Inflammation Research (2023)
-
Cultural adaptation and validation of the Malay Chronic Kidney Disease Self-management instrument (MCKD-SM)
BMC Nephrology (2022)
-
Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
Trials (2021)